AngioDynamics Divests Dialysis Portfolio And Biopsy Product Line To Merit Medical Systems For $100M
AngioDynamics, Inc. (NASDAQ: ANGO)
AstraZeneca’s Add On Treatment With Standard Care Improves Hemoglobin Levels In Rare Blood Disorder
AstraZeneca Plc (NASDAQ: AZN)
AstraZeneca Inks Over $2B Agreement For Cell Therapies Targeting Diabetes
AstraZeneca plc (NASDAQ: AZN) has entered into a
Unanimous Support for AstraZeneca and Sanofi’s Nirsevimab: Next Generation RSV Treatment on the Horizon
The FDA's Antimicrobial Drugs Advisory Committee has voted unanimously 21 to 0 that AstraZeneca plc (NASDAQ: AZN) and Sanofi SA's (NASDAQ: SNY) nirsevimab has a favorable benefit-risk profile t
FDA Readies Proposal for Increased Oversight on Lab-developed Tests
The FDA is preparing to increase regulation of a widely used class of tests conducted by laboratories to detect cancer, measure cholesterol, and identify other health issues.
The FDA is developing a proposal to ensure these tests' effectiveness and accuracy.
Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
Astellas Pharma Inc (OTC: ALPMF) (OTC: ALPMY) decided to license and advance a gene therapy from Kate Therapeutics for a debilitating muscle disorder known as
Bernie Sanders Takes on High Costs of Alzheimer’s Treatment Leqembi, Calls Price Tag ‘Unconscionable’
Senator Bernie Sanders urged the U.S.
EndeavorOTC Elevates ADHD Treatment: Unprecedented Mobile Game Therapy for Adults
Akili Inc (NASDAQ: AKLI) released EndeavorOTC, a new immersive mobile video game treatment clinically proven to improve attention and focus,
Arvinas Releases Early Cut Data Showing Encouraging Efficacy In Prostate Cancer With Certain Mutations
Arvinas Inc (NASDAQ: ARVN) announced interim data from its Phase 1/2 dose escalation and expansion trial of ARV-766 in metastatic
